Cargando…
Evolutionary trajectory of SARS-CoV-2 and emerging variants
The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more recently, the independent evolution of multiple SARS-CoV-2 variants has generated renewed interest in virus evolution and cross-species transmission. While all known human coronaviruses (HCoV...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361246/ https://www.ncbi.nlm.nih.gov/pubmed/34389034 http://dx.doi.org/10.1186/s12985-021-01633-w |
_version_ | 1783737922505146368 |
---|---|
author | Singh, Jalen Pandit, Pranav McArthur, Andrew G. Banerjee, Arinjay Mossman, Karen |
author_facet | Singh, Jalen Pandit, Pranav McArthur, Andrew G. Banerjee, Arinjay Mossman, Karen |
author_sort | Singh, Jalen |
collection | PubMed |
description | The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more recently, the independent evolution of multiple SARS-CoV-2 variants has generated renewed interest in virus evolution and cross-species transmission. While all known human coronaviruses (HCoVs) are speculated to have originated in animals, very little is known about their evolutionary history and factors that enable some CoVs to co-exist with humans as low pathogenic and endemic infections (HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1), while others, such as SARS-CoV, MERS-CoV and SARS-CoV-2 have evolved to cause severe disease. In this review, we highlight the origins of all known HCoVs and map positively selected for mutations within HCoV proteins to discuss the evolutionary trajectory of SARS-CoV-2. Furthermore, we discuss emerging mutations within SARS-CoV-2 and variants of concern (VOC), along with highlighting the demonstrated or speculated impact of these mutations on virus transmission, pathogenicity, and neutralization by natural or vaccine-mediated immunity. |
format | Online Article Text |
id | pubmed-8361246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83612462021-08-13 Evolutionary trajectory of SARS-CoV-2 and emerging variants Singh, Jalen Pandit, Pranav McArthur, Andrew G. Banerjee, Arinjay Mossman, Karen Virol J Review The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more recently, the independent evolution of multiple SARS-CoV-2 variants has generated renewed interest in virus evolution and cross-species transmission. While all known human coronaviruses (HCoVs) are speculated to have originated in animals, very little is known about their evolutionary history and factors that enable some CoVs to co-exist with humans as low pathogenic and endemic infections (HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1), while others, such as SARS-CoV, MERS-CoV and SARS-CoV-2 have evolved to cause severe disease. In this review, we highlight the origins of all known HCoVs and map positively selected for mutations within HCoV proteins to discuss the evolutionary trajectory of SARS-CoV-2. Furthermore, we discuss emerging mutations within SARS-CoV-2 and variants of concern (VOC), along with highlighting the demonstrated or speculated impact of these mutations on virus transmission, pathogenicity, and neutralization by natural or vaccine-mediated immunity. BioMed Central 2021-08-13 /pmc/articles/PMC8361246/ /pubmed/34389034 http://dx.doi.org/10.1186/s12985-021-01633-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Singh, Jalen Pandit, Pranav McArthur, Andrew G. Banerjee, Arinjay Mossman, Karen Evolutionary trajectory of SARS-CoV-2 and emerging variants |
title | Evolutionary trajectory of SARS-CoV-2 and emerging variants |
title_full | Evolutionary trajectory of SARS-CoV-2 and emerging variants |
title_fullStr | Evolutionary trajectory of SARS-CoV-2 and emerging variants |
title_full_unstemmed | Evolutionary trajectory of SARS-CoV-2 and emerging variants |
title_short | Evolutionary trajectory of SARS-CoV-2 and emerging variants |
title_sort | evolutionary trajectory of sars-cov-2 and emerging variants |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361246/ https://www.ncbi.nlm.nih.gov/pubmed/34389034 http://dx.doi.org/10.1186/s12985-021-01633-w |
work_keys_str_mv | AT singhjalen evolutionarytrajectoryofsarscov2andemergingvariants AT panditpranav evolutionarytrajectoryofsarscov2andemergingvariants AT mcarthurandrewg evolutionarytrajectoryofsarscov2andemergingvariants AT banerjeearinjay evolutionarytrajectoryofsarscov2andemergingvariants AT mossmankaren evolutionarytrajectoryofsarscov2andemergingvariants |